enVVeno Medical Corporation
Share · US29415J1300 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of enVVeno Medical Corporation
No Price
Company Profile for enVVeno Medical Corporation Share
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Company Data
Name enVVeno Medical Corporation
Company enVVeno Medical Corporation
Website
https://www.envveno.com
Primary Exchange 
UTC
UTC
ISIN US29415J1300
Asset Class Share
Sector Healthcare
Industry Medical - Specialties
CEO Robert A. Berman
Country United States of America
Currency USD
Employees 0,0 T
Address 70 Doppler, Irvine
IPO Date 2021-02-18
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | NVNBW |
More Shares
Investors who hold enVVeno Medical Corporation also have the following shares in their portfolio:
